Literature DB >> 34347215

Cerebral venous thrombosis: a retrospective unicentric analysis of clinical and neuroimaging characteristics.

Jovan Petrović1, Tamara Švabić2, Jasna Zidverc-Trajković1,2, Predrag Stanarčević2, Dejana Jovanović1,2, Milija Mijajlović3,4.   

Abstract

Thrombosis of dural sinuses and/or cerebral veins (CVT) is an uncommon form of stroke, usually affecting young individuals. It has a variable clinical presentation ranging from mild cases presenting only headaches, to severe cases featuring encephalopathy, coma or status epilepticus. A retrospective cross-sectional study of patients treated in the outpatient department and in-hospital during the period from 2014 to 2020 at the Neurology Clinic-University Clinical Centre of Serbia was conducted. Forty-nine patients (24 men; 25 women) were included in the study. Twenty-three patients (46.9%) suffered a subacute form of CVT (48 h-4 weeks), 19 (38.8%) presented with an acute form (< 48 h) and 7 (14.3%) with a chronic form (> 4 weeks). Around 75% of patients reported headaches during disease course. Focal neurological deficit (FND) was observed in 27 (55.1%) patients. Patients who did not report headaches (22.4%) presented with more severe symptoms (seizures and coma). More than 70% of patients had no radiologically evident brain parenchymal lesion. The most frequent locations of CVT were transverse sinus (79.6%), sigmoid sinus (44.9%) and superior sagittal sinus (36.7%). Thrombosis of more than one sinus/vein occurred in 33 (67.3%) patients. Hereditary thrombophilia was observed in 9 (18.4%) patients, 11 (22.4%) patients had some type of infection and 20% of women reported OCT usage. As much as 25% of cases remained without evident risk factors. The most common symptom in our cohort was acute unilateral throbbing headache of high intensity, while patients without headaches had more severe symptoms.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Cerebral venous thrombosis; Clinical presentation; Headache; Neuroimaging; Risk factors

Mesh:

Year:  2021        PMID: 34347215     DOI: 10.1007/s10072-021-05514-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  22 in total

1.  Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study.

Authors:  Sharon Devasagayam; Ben Wyatt; James Leyden; Timothy Kleinig
Journal:  Stroke       Date:  2016-07-19       Impact factor: 7.914

2.  Causes and predictors of death in cerebral venous thrombosis.

Authors:  Patrícia Canhão; José M Ferro; Arne G Lindgren; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2005-07-07       Impact factor: 7.914

Review 3.  Cerebral Venous Thrombosis: A Comprehensive Review.

Authors:  Pretty Sara Idiculla; Dhineshreddy Gurala; Manikandan Palanisamy; Rajendran Vijayakumar; Sindhu Dhandapani; Elanagan Nagarajan
Journal:  Eur Neurol       Date:  2020-09-02       Impact factor: 1.710

Review 4.  Cerebral venous thrombosis.

Authors:  Suzanne M Silvis; Diana Aguiar de Sousa; José M Ferro; Jonathan M Coutinho
Journal:  Nat Rev Neurol       Date:  2017-08-18       Impact factor: 42.937

Review 5.  Cerebral venous sinus thrombosis.

Authors:  M Capecchi; M Abbattista; I Martinelli
Journal:  J Thromb Haemost       Date:  2018-07-11       Impact factor: 5.824

6.  A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study.

Authors:  Taskin Duman; Derya Uluduz; Ipek Midi; Hesna Bektas; Yuksel Kablan; Basak K Goksel; Aysel Milanlioglu; Dilek Necioglu Orken; Ufuk Aluclu
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-06-02       Impact factor: 2.136

7.  European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology.

Authors:  José M Ferro; Marie-Germaine Bousser; Patrícia Canhão; Jonathan M Coutinho; Isabelle Crassard; Francesco Dentali; Matteo di Minno; Alberto Maino; Ida Martinelli; Florian Masuhr; Diana Aguiar de Sousa; Jan Stam
Journal:  Eur Stroke J       Date:  2017-07-21

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  Risk of Cerebral Venous Thrombosis in Obese Women.

Authors:  Susanna M Zuurbier; Marcel Arnold; Saskia Middeldorp; Anne Broeg-Morvay; Suzanne M Silvis; Mirjam R Heldner; Julia Meisterernst; Banne Nemeth; Eva R Meulendijks; Jan Stam; Suzanne C Cannegieter; Jonathan M Coutinho
Journal:  JAMA Neurol       Date:  2016-05-01       Impact factor: 18.302

Review 10.  Headache in cerebral venous thrombosis.

Authors:  Angelo Aliprandi; Paolo Borelli; Valeria Polonia; Andrea Salmaggi
Journal:  Neurol Sci       Date:  2020-12       Impact factor: 3.307

View more
  2 in total

1.  Effects of low molecular weight heparin combined with hyperbaric oxygen on neurologic function and coagulation factors in patients with intracranial venous thrombosis.

Authors:  Bo-Feng Liu; Xiao-Hui Liu; Xiao-Hui Dong; Ning Ma; Hui-Ping Zhang; Li-Li Jiang; Yan-Qing Liu
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Cavernous sinus thrombosis associated with intraparenchymal hemorrhage and brainstem venous infarction as a rare complication of fronto-orbital infection.

Authors:  F Rosa; P Renzetti; L Castellan; L Roccatagliata
Journal:  Neurol Sci       Date:  2021-10-18       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.